New ADA Care Requirements in Diabetes; FDA Clears AI-Primarily based Diagnostic; Hashish and T1D

It’s that time again: The American Diabetes Association published its annual Standards of Medical Care in Diabetes with new updates on the management of diabetes and prediabetes. (Diabetes treatment)

Although childhood obesity rates have been rising steadily before, the COVID-19 pandemic only seemed to accelerate that trend in Massachusetts. (JAMA Pediatrics)

The FDA has approved Koios Medical’s new artificial intelligence technology capable of diagnosing thyroid and breast cancer in just 2 seconds. (FierceBiotech)

The detailed results of the NIH Study on Responsive Parenting focused on the prevention of obesity in firstborns. “The vast majority of parents have multiple children, and therefore a parenting strategy that can be taught once and then benefits subsequent children can be a way forward to curb the growing problem of child obesity,” said Voula Osganian, MD, ScD, MPH, of the National Institute of Diabetes and Digestive and Kidney Diseases, in a statement.

Consuming more salt was associated with higher fasting plasma glucose and HbA1c levels in people with type 2 diabetes. (Diabetes, Metabolic Syndrome, and Obesity: Goals and Therapy)

Cannabis users with type 1 diabetes saw significantly higher bicarbonate and pH levels – especially 7.4 or higher – when they presented diabetic ketoacidosis.

Researchers at the University of Exeter in England are developing a new treatment that targets the brain to fight off hypoglycemia. (Science daily)

The first participant was admitted to the Phase I / II clinical proof-of-concept trial for a novel treatment for thyroid eye disease, Viridian Therapeutics announced.

  • Kristen Monaco is a salaried writer specializing in endocrinology, psychiatry, and nephrology. She has been with the company from her New York City office since 2015.